These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12640108)

  • 1. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases.
    McCarthy DM; Hruban RH; Argani P; Howe JR; Conlon KC; Brennan MF; Zahurak M; Wilentz RE; Cameron JL; Yeo CJ; Kern SE; Klimstra DS
    Mod Pathol; 2003 Mar; 16(3):272-8. PubMed ID: 12640108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis.
    Beghelli S; Orlandini S; Moore PS; Talamini G; Capelli P; Zamboni G; Falconi M; Scarpa A
    Virchows Arch; 2002 Jul; 441(1):19-24. PubMed ID: 12111196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts.
    Argani P; Shaukat A; Kaushal M; Wilentz RE; Su GH; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Cancer; 2001 Apr; 91(7):1332-41. PubMed ID: 11283934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.
    Wilentz RE; Su GH; Dai JL; Sparks AB; Argani P; Sohn TA; Yeo CJ; Kern SE; Hruban RH
    Am J Pathol; 2000 Jan; 156(1):37-43. PubMed ID: 10623651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
    Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
    Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.
    Iacobuzio-Donahue CA; Klimstra DS; Adsay NV; Wilentz RE; Argani P; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Am J Pathol; 2000 Sep; 157(3):755-61. PubMed ID: 10980115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression.
    Iacobuzio-Donahue CA; Wilentz RE; Argani P; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Am J Surg Pathol; 2000 Nov; 24(11):1544-8. PubMed ID: 11075857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
    Ohike N; Kim GE; Tajiri T; Krasinskas A; Basturk O; Coban I; Bandyopadhyay S; Morohoshi T; Goodman M; Kooby DA; Sarmiento JM; Adsay NV
    Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
    Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
    J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.
    Ruemmele P; Dietmaier W; Terracciano L; Tornillo L; Bataille F; Kaiser A; Wuensch PH; Heinmoeller E; Homayounfar K; Luettges J; Kloeppel G; Sessa F; Edmonston TB; Schneider-Stock R; Klinkhammer-Schalke M; Pauer A; Schick S; Hofstaedter F; Baumhoer D; Hartmann A
    Am J Surg Pathol; 2009 May; 33(5):691-704. PubMed ID: 19252434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations.
    Scarpa A; Capelli P; Zamboni G; Oda T; Mukai K; Bonetti F; Martignoni G; Iacono C; Serio G; Hirohashi S
    Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterisation of six human biliary tract cancer cell lines.
    Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
    Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
    Hua Z; Zhang YC; Hu XM; Jia ZG
    World J Gastroenterol; 2003 Dec; 9(12):2764-7. PubMed ID: 14669329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
    Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
    Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of K-ras gene mutations in rare pancreatic and ampullary tumours.
    Ebert MP; Hoffmann J; Schneider-Stock R; Kasper HU; Schulz HU; Lippert H; Roessner A; Malfertheiner P
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1025-9. PubMed ID: 9895049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
    Xue Y; Vanoli A; Balci S; Reid MM; Saka B; Bagci P; Memis B; Choi H; Ohike N; Tajiri T; Muraki T; Quigley B; El-Rayes BF; Shaib W; Kooby D; Sarmiento J; Maithel SK; Knight JH; Goodman M; Krasinskas AM; Adsay V
    Mod Pathol; 2017 Feb; 30(2):255-266. PubMed ID: 27739441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.
    Mikhitarian K; Pollen M; Zhao Z; Shyr Y; Merchant NB; Parikh A; Revetta F; Washington MK; Vnencak-Jones C; Shi C
    Mod Pathol; 2014 May; 27(5):665-74. PubMed ID: 24186143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas.
    Bartsch D; Barth P; Bastian D; Ramaswamy A; Gerdes B; Chaloupka B; Deiss Y; Simon B; Schudy A
    Cancer Lett; 1999 May; 139(1):43-9. PubMed ID: 10408907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.